KMB Kimberly-Clark
Durable but slow-growing staples franchise; fair value near market, with Kenvue as the swing factor.
The story
Kimberly-Clark is a mature consumer-staples franchise (Huggies, Kleenex, Cottonelle, Kotex) with strong brands and scale in North America. Headline revenue has shrunk from divestitures and the international tissue JV with Suzano, not from collapsing demand. Organic growth runs low single digits, and productivity programs are rebuilding margins. The pending Kenvue acquisition adds a large stock-and-cash transformation with integration risk, and it is not reflected in these standalone numbers.
Growth of 2% reflects organic volume and price on a cleaned-up portfolio; the 5-year revenue CAGR is distorted by divestitures, so I do not extrapolate it. The margin moves from 14.9% to 16%, sustainable for branded staples given cost-savings programs, but stays below peak levels because of private-label pressure. Sales-to-capital of about 2.0 matches history, and beta sits at the staples anchor of 0.7.
Value drivers
| Revenue growth (Y1) | 2.0% |
| Terminal growth | 2.5% |
| Forecast horizon | 7y |
| Target operating margin | 16.0% |
| Years to target margin | 4 |
| Sales-to-capital | 2.00 |
| Beta | 0.70 |
| Failure probability | 2.0% |
| Cost of capital (WACC) | 7.8% |
| Terminal WACC | 8.9% |
Valuation bridge
| PV of explicit FCFF | 9.47B |
| PV of terminal value | 17.38B |
| Equity value | 19.82B |
| ÷ shares → per share | $59.58 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 16.91B | 2.0% | 15.2% | 1.82B | 165.82M | 1.65B | 1.53B |
| 2 | 17.27B | 2.1% | 15.5% | 1.89B | 176.18M | 1.71B | 1.48B |
| 3 | 17.64B | 2.2% | 15.7% | 1.96B | 187.05M | 1.78B | 1.42B |
| 4 | 18.04B | 2.2% | 16.0% | 2.04B | 198.45M | 1.85B | 1.37B |
| 5 | 18.46B | 2.3% | 16.0% | 2.09B | 210.43M | 1.88B | 1.29B |
| 6 | 18.90B | 2.4% | 16.0% | 2.14B | 223.03M | 1.92B | 1.22B |
| 7 | 19.38B | 2.5% | 16.0% | 2.20B | 236.30M | 1.96B | 1.16B |
Key risks
- Kenvue integration and dilution: overpaying, synergy shortfall, higher leverage
- Private-label share gains and retailer pricing pressure on diapers and tissue
- Pulp and resin input-cost inflation compressing margins
- Declining birth rates in developed markets weighing on Huggies volume
Catalysts
- Kenvue deal close and synergy delivery updates
- Margin expansion from Powering Care productivity savings and IFP JV deconsolidation